2749 E. PARLEYS WAY, SALT LAKE CITY, UT
Annual Report to Security Holders
Reports Fourth Quarter 2025 Financial Results
Investor Presentation
Landmark Study Finds Blood Test Reduces Earliest Preterm Births and Newborn Complications
Announces Publication Acceptance for PRIME Study
Financial Results, Press Release
Reg. FD
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload